Invention Grant
- Patent Title: Brain penetrant amylin receptor based peptides for Alzheimer's disease
-
Application No.: US15705789Application Date: 2017-09-15
-
Publication No.: US10766940B2Publication Date: 2020-09-08
- Inventor: Jack Jhamandas , Rania Soudy , Kamaljit Kaur , Wen Fu , David MacTavish , Aarti Patel
- Applicant: The Governors of the University of Alberta
- Applicant Address: CA Edmonton
- Assignee: The Governors of the University of Alberta
- Current Assignee: The Governors of the University of Alberta
- Current Assignee Address: CA Edmonton
- Agency: Bozicevic, Field & Francis LLP
- Agent Rudy J. Ng
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/575 ; A61P25/28 ; C07K14/585
Abstract:
Amylin receptor antagonists capable of binding to the amylin receptor and inhibiting activity of amylin or amyloid-beta protein are provided. The amylin receptor antagonists can be administered in the form of pharmaceutical compositions or the like. Methods for preparing and using the amylin receptor antagonists for treating, preventing, or ameliorating Alzheimer's disease are also provided.
Public/Granted literature
- US20180134763A1 BRAIN PENETRANT AMYLIN RECEPTOR BASED PEPTIDES FOR ALZHEIMER'S DISEASE Public/Granted day:2018-05-17
Information query
IPC分类:
